24 results on '"Reissier S"'
Search Results
2. Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis
- Author
-
Pilmis, B., primary, Lourtet-Hascoët, J., additional, Barraud, O., additional, Piau, C., additional, Isnard, C., additional, Hery-Arnaud, G., additional, Amara, M., additional, Merens, A., additional, Farfour, E., additional, Thomas, E., additional, Jacquier, H., additional, Zahar, J.-R., additional, Bonnet, E., additional, Monnier, A. Le, additional, Cattoir, V., additional, Corvec, S., additional, Boutoille, D., additional, de Ponfilly, G. Péan, additional, and Reissier, S., additional
- Published
- 2019
- Full Text
- View/download PDF
3. Intérêt de la PCR multiplex dans les surinfections d’ulcères cutanés
- Author
-
Reissier, S., primary, Lourtet, J., additional, Adjiman, L., additional, Mizrahi, A., additional, Tiercelet, K., additional, Couzigou, C., additional, Nguyen Van, J., additional, Pilmis, B., additional, and Lazareth, I., additional
- Published
- 2018
- Full Text
- View/download PDF
4. Infections sur rachis instrumenté : revue des cas 2010–2016
- Author
-
Reissier, S., primary, Lourtet, J., additional, Couzigou, C., additional, Riouallon, G., additional, Wolff, S., additional, Meyssonnier, V., additional, Mohamed-Hadj, A., additional, Jouffroy, P., additional, and Le Monnier, A., additional
- Published
- 2018
- Full Text
- View/download PDF
5. Infections du site opératoire après chirurgie instrumentée du rachis : épidémiologie sur 7 ans de suivi
- Author
-
Reissier, S., primary, Couzigou, C., additional, Lourtet, J., additional, Vidal, B., additional, Perniceni, L., additional, Mohamed-Hadj, A., additional, Riouallon, G., additional, Jouffroy, P., additional, and Le Monnier, A., additional
- Published
- 2018
- Full Text
- View/download PDF
6. Étude de l’antibiogramme rapide sur milieu solide MHR (i2a) directement à partir des urines
- Author
-
Perillaud, C., primary, Pilmis, B., additional, Diep, J., additional, Perreau, S., additional, Ruffier d’Epenoux, L., additional, Reissier, S., additional, Mizrahi, A., additional, Lourtet, J., additional, Le Monnier, A., additional, and Nguyen Van, J.C., additional
- Published
- 2017
- Full Text
- View/download PDF
7. Antibiogramme rapide en milieu solide sur milieu MHR (i2a) à partir du flacon d’hémoculture
- Author
-
Perillaud, C., primary, Pilmis, B., additional, Diep, J., additional, Perreau, S., additional, Ruffier d’Epenoux, L., additional, Reissier, S., additional, Mizrahi, A., additional, Lourtet, J., additional, Le Monnier, A., additional, and Nguyen Van, J.C., additional
- Published
- 2017
- Full Text
- View/download PDF
8. Activité de la daptomycine et émergence de résistance dans un modèle expérimental d’endocardite à Enterococcus faecium résistant à la vancomycine
- Author
-
Reissier, S., primary, Saleh-Mghir, A., additional, Guérin, F., additional, Massias, L., additional, Ghout, I., additional, Sinel, C., additional, Cattoir, V., additional, and Crémieux, A.C., additional
- Published
- 2017
- Full Text
- View/download PDF
9. Daptomycine et infections sévères à entérocoques
- Author
-
Reissier, S.
- Abstract
Les entérocoques sont des germes du microbiote intestinal fréquemment impliqués dans les infections liées aux soins. Les glycopeptides sont habituellement utilisés dans le traitement des infections sévères à entérocoques, notamment Enterococcus faeciumsouvent résistant aux pénicillines. Cependant, la prévalence des entérocoques résistants à la vancomycine est élevée dans certains pays (ex. États-Unis) et la daptomycine apparaît comme un antibiotique de choix pour le traitement des infections sévères à ERV. L’utilisation de fortes doses (>6mg/kg) semble nécessaire mais les posologies optimales, notamment pour les souches dont la CMI est proche du seuil de sensibilité (4mg/L), n’ont pas encore été établies. Des résistances sous traitement à l’origine d’échecs thérapeutiques ainsi que des cas de résistance de novoà la daptomycine sont décrits dans la littérature. À l’heure actuelle, tous les mécanismes de résistance des entérocoques à la daptomycine ne sont pas encore identifiés. Cet article décrit les mécanismes de résistance connus, à ce jour, ainsi que les posologies utilisées dans le traitement des infections sévères à ERV.
- Published
- 2024
- Full Text
- View/download PDF
10. Microbiological Profile of Instrumented Spinal Infections: 10-Year Study at a French Spine Center.
- Author
-
Reissier S, Couzigou C, Courseau R, Aubert E, Le Monnier A, Bonnet E, Upex P, Moreau PE, Riouallon G, and Lourtet-Hascoët J
- Abstract
Objective: The objective was to compare the microbiological characteristics and treatment of early and late surgical site infections (SSIs) in instrumented spinal surgery., Methods: Those patients admitted for SSIs in a single center between January 2010 and December 2022 were included. The subjects were divided into early (eSSIs) and late (lSSIs) SSIs, and demographic, microbiological, treatment, and follow-up data were collected., Results: Instrumented spinal surgery was performed in 2136 patients. Ninety-six cases of infections were identified (prevalence = 4.5%), with 47.9% eSSIs and 52.1% lSSIs. In 58.7% of the cases, the eSSIs were monomicrobial: Staphylococcus aureus (37%) and Enterobacterales (33.3%) were the main bacteria involved. In 66% of the cases, the lSSIs, were monomicrobial: Cutibacterium acnes (30.3%) and staphylococci were predominant. Enterobacterales were isolated in more than 70% of the polymicrobial samples in both the eSSIs and lSSIs. The treatment of the eSSIs mostly consisted of lavage-debridement surgery associated with antibiotic treatment, while the treatment of the lSSIs combined hardware removal or replacement and long-duration antibiotic treatment. A negative outcome was observed in 17.1% of the eSSIs and 5.7% of the lSSIs. Enterobacterales were associated with negative outcomes of eSSIs., Conclusions: Enterobacterales were found in most of the polymicrobial infections regardless of the time of infection onset. Further large studies should be conducted to precisely determine the management and prevention regarding the increasing Gram-negative bacteria SSIs.
- Published
- 2024
- Full Text
- View/download PDF
11. Multicenter study to assess the use of BL-DetecTool for the detection of CTX-M-type ESBLs and carbapenemases directly from clinical specimens.
- Author
-
Fernandez-Pittol M, Bosch J, Ballesté-Delpierre C, Gonzalez C, Vasilakopoulou A, Berbel D, Riccobono E, Gatermann S, Kamotsay K, Reissier S, Szabo D, Aszalos AZ, Francius L, Volland H, Stankov-Pugès M, Rosenmöller M, Naas T, and Vila J
- Subjects
- Humans, Bacterial Proteins, Microbial Sensitivity Tests, Anti-Bacterial Agents, beta-Lactamases analysis, Anti-Infective Agents
- Abstract
Antimicrobial resistance (AMR) is one of the major public health problems worldwide. Multiple strategies have been put in place to address this problem. One of them is the rapid detection of the mechanisms of resistance, such as extended-spectrum beta-lactamases (ESBLs) and/or carbapenemases. We conducted a multicenter study that included nine European centers for the assessment of prototypes of a novel lateral flow immunoassay-based device (BL-DetecTool) for a rapid detection of ESBL (NG-Test CTX-M-MULTI DetecTool) and/or carbapenemases (NG-Test CARBA 5 DetecTool) from Enterobacterales and Pseudomonas aeruginosa in positive urine, positive blood cultures, and rectal swabs. We performed a prospective analysis between January 2021 and June 2022, including overall 22,010 samples. Based on each hospital information, the sensitivity to detect CTX-M was 84%-100%, 90.9%-100%, and 75%-100% for urine, positive blood cultures, and enriched rectal swabs, respectively. On the other hand, the sensitivity to detect carbapenemases was 42.8%-100%, 75%-100%, and 66.6%-100% for urine, positive blood cultures, and enriched rectal swab, respectively. BL-DetecTool allows a rapid and reliable detection of ESBL and carbapenemases directly from urine, positive blood cultures, or enriched rectal swabs, being an easy technique to implement in the workflow of clinical microbiology laboratories., Importance: The assessed rapid assay to detect CTX-M beta-lactamases and carbapenemases directly from clinical samples can favor in the rapid detection of these mechanisms of resistance and hence the administration of a more adequate antimicrobial treatment., Competing Interests: H.V. has filed on behalf of CEA a patent for the SPID platform. M.S.P. and L.F. are employees of NG Biotech and were involved in the BL-DetecTool manufacturing but not in the data analysis. All the other authors declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
12. A multicentre evaluation of the NG-test DetecTool OXA-23 for the rapid detection of OXA-23 carbapenemase directly from blood cultures.
- Author
-
Vasilakopoulou A, Naas T, Gonzalez C, Vila J, Szabo D, Riccobono E, Kamotsay K, Reissier S, Berbel D, Aszalos AZ, Rosenmoller M, Stankov-Puges M, Georgiou PC, Vourli S, Volland H, and Pournaras S
- Abstract
Objectives: A multicentre study evaluating NG-Test DetecTool OXA-23 for the detection of OXA-23 carbapenemase directly from positive blood cultures (PBCs)., Methods: The NG-Test DetecTool OXA-23 is an immunoassay that integrates a sample preparation device. We evaluated NG-Test DetecTool OXA-23 on 189 spiked and 126 clinical PBCs. The clinical samples' standard-of-care procedure consisted of bacterial identification from the first day of positivity by MALDI-TOF MS, conventional culture and antimicrobial susceptibility testing. The immunoassay results were verified molecularly. The strains used for the spiked samples consisted of well-characterized Acinetobacter baumannii and Proteus mirabilis strains., Results: The NG-Test DetecTool OXA-23 was evaluated on 315 PBCs and revealed sensitivity of 100% (95% CI: 98.21%-100.00%) and specificity of 100% (95% CI: 96.73%-100.00%). It provided 204 true-positive results for OXA-23 in 196 bottles with carbapenem-resistant A. baumannii (CRAB) and 8 bottles with carbapenem-resistant P. mirabilis and also provided 111 true-negative results. There were no false-positive and no false-negative results. Among the 315 PBCs studied, 83 clinical blood cultures collected in the ICU of a Greek university hospital, which were tested prospectively, all yielded CRAB, and OXA-23 was correctly detected in all samples from the first day of positivity using the NG-Test DetecTool OXA-23., Conclusions: The NG-Test DetecTool OXA-23 has exhibited excellent sensitivity and specificity for OXA-23 detection in PBCs and can provide valuable information for appropriate selection of antibiotic therapy and early implementation of infection control measures., (© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.)
- Published
- 2024
- Full Text
- View/download PDF
13. The Role of Next-Generation Sequencing (NGS) in the Management of Tuberculosis: Practical Review for Implementation in Routine.
- Author
-
Beviere M, Reissier S, Penven M, Dejoies L, Guerin F, Cattoir V, and Piau C
- Abstract
Next-generation sequencing (NGS) has modernized the field of tuberculosis (TB) research by enabling high-throughput sequencing of the entire genome of Mycobacterium tuberculosis (MTB), which is the causative agent of TB. NGS has provided insights into the genetic diversity of MTB, which are crucial for understanding the evolution and transmission of the disease, and it has facilitated the identification of drug-resistant strains, enabling rapid and accurate tailoring of treatment. However, the high cost and the technical complexities of NGS currently limit its widespread use in clinical settings. International recommendations are thus necessary to facilitate the interpretation of polymorphisms, and an experimental approach is still necessary to correlate them to phenotypic data. This review aims to present a comparative, step-by-step, and up-to-date review of the techniques available for the implementation of this approach in routine laboratory workflow. Ongoing research on NGS for TB holds promise for improving our understanding of the disease and for developing more efficacious treatments.
- Published
- 2023
- Full Text
- View/download PDF
14. Temocillin Resistance in the Enterobacter cloacae Complex Is Conferred by a Single Point Mutation in BaeS, Leading to Overexpression of the AcrD Efflux Pump.
- Author
-
Guérin F, Gravey F, Reissier S, Penven M, Michaux C, Le Hello S, and Cattoir V
- Subjects
- Enterobacter cloacae genetics, Enterobacter cloacae metabolism, Escherichia coli genetics, Point Mutation, Microbial Sensitivity Tests, Membrane Transport Proteins genetics, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents metabolism
- Abstract
The Enterobacter cloacae complex (ECC) has become a major opportunistic pathogen with antimicrobial resistance issues. Temocillin, an "old" carboxypenicillin that is remarkably stable toward β-lactamases, has been used as an alternative for the treatment of multidrug-resistant ECC infections. Here, we aimed at deciphering the never-investigated mechanisms of temocillin resistance acquisition in Enterobacterales . By comparative genomic analysis of two clonally related ECC clinical isolates, one susceptible (Temo_S [MIC of 4 mg/L]) and the other resistant (Temo_R [MIC of 32 mg/L]), we found that they differed by only 14 single-nucleotide polymorphisms, including one nonsynonymous mutation (Thr175Pro) in the two-component system (TCS) sensor histidine kinase BaeS. By site-directed mutagenesis in Escherichia coli CFT073, we demonstrated that this unique change in BaeS was responsible for a significant (16-fold) increase in temocillin MIC. Since the BaeSR TCS regulates the expression of two resistance-nodulation-cell division (RND)-type efflux pumps (namely, AcrD and MdtABCD) in E. coli and Salmonella, we demonstrated by quantitative reverse transcription-PCR that mdtB , baeS , and acrD genes were significantly overexpressed (15-, 11-, and 3-fold, respectively) in Temo_R. To confirm the role of each efflux pump in this mechanism, multicopy plasmids harboring mdtABCD or acrD were introduced into either Temo_S or the reference strain E. cloacae subsp. cloacae ATCC 13047. Interestingly, only the overexpression of acrD conferred a significant increase (from 8- to 16-fold) of the temocillin MIC. Altogether, we have shown that temocillin resistance in the ECC can result from a single BaeS alteration, likely resulting in the permanent phosphorylation of BaeR and leading to AcrD overexpression and temocillin resistance through enhanced active efflux., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
15. Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates.
- Author
-
Reissier S, Penven M, Guérin F, and Cattoir V
- Abstract
Anaerobic bacteria are normal inhabitants of the human commensal microbiota and play an important role in various human infections. Tedious and time-consuming, antibiotic susceptibility testing is not routinely performed in all clinical microbiology laboratories, despite the increase in antibiotic resistance among clinically relevant anaerobes since the 1990s. β-lactam and metronidazole are the key molecules in the management of anaerobic infections, to the detriment of clindamycin. β-lactam resistance is usually mediated by the production of β-lactamases. Metronidazole resistance remains uncommon, complex, and not fully elucidated, while metronidazole inactivation appears to be a key mechanism. The use of clindamycin, a broad-spectrum anti-anaerobic agent, is becoming problematic due to the increase in resistance rate in all anaerobic bacteria, mainly mediated by Erm-type rRNA methylases. Second-line anti-anaerobes are fluoroquinolones, tetracyclines, chloramphenicol, and linezolid. This review aims to describe the up-to-date evolution of antibiotic resistance, give an overview, and understand the main mechanisms of resistance in a wide range of anaerobes.
- Published
- 2023
- Full Text
- View/download PDF
16. Small RNA-mediated regulation of the tet(M) resistance gene expression in Enterococcus faecium.
- Author
-
Le Neindre K, Dejoies L, Reissier S, Guérin F, Felden B, and Cattoir V
- Subjects
- Bacterial Proteins genetics, Enterococcus faecalis genetics, Gene Expression, RNA, Tetracyclines, Enterococcus faecium genetics
- Abstract
We investigated the role of a novel small RNA expressed in Enterococcus faecium (named Ern0030). We revealed that ern0030 was encoded within the 5'untranslated region of tet(M), a gene conferring tetracycline resistance through ribosomal protection. By RACE mapping, we accurately determined the boundaries of ern0030, which corresponded to Ptet. This upstream sequence of tet(M), Ptet, was previously described within transcriptional attenuation mechanism. Here, Northern blot analyses revealed three transcripts of different lengths (ca. 230, 150 and 100 nucleotides) expressed from Ptet. Phenotypically, the total deletion of ern0030 conferred a decrease in tetracycline MICs that was consistent with gene expression data showing no significant tet(M) induction under tetracycline SIC in ern0030-deleted mutant as opposed to a 10-fold increase of tet(M) expression in the wild-type strain. We investigated the transcriptional attenuation mechanism by toeprint assay. Whereas the expected tet(M) ribosome-binding site (RBS) was detected, the RBS of the putative leader peptide was not highlighted by toeprint assay, suggesting the transcriptional attenuation was unlikely. Here, we demonstrate that Ern0030 has a role in regulation of tet(M) expression and propose a novel model of tet(M) regulation alternative or complementary to transcriptional attenuation., Competing Interests: Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest., (Copyright © 2022 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. The Regulatory RNA ern0160 Confers a Potential Selective Advantage to Enterococcus faecium for Intestinal Colonization.
- Author
-
Reissier S, Le Neindre K, Bordeau V, Dejoies L, Le Bot A, Felden B, Cattoir V, and Revest M
- Abstract
The aim of this study was to evaluate the role of the regulatory small RNA (sRNA) Ern0160 in gastrointestinal tract (GIT) colonization by Enterococcus faecium . For this purpose, four strains of E. faecium were used, Aus0004 (WT), an ern0160 -deleted Aus0004 mutant (Δ0160), a trans -complemented Δ0160 strain overexpressing ern0160 (Δ0160_0160), and a strain Δ0160 with an empty pAT29 vector (Δ0160_pAT29). Strains were studied both in vitro and in vivo , alone and in competitive assays. In in vitro experiments, no difference was observed between WT and Δ0160 strains cultured single while Δ0160_0160 strain grew more slowly than Δ0160_pAT29. In competitive assays, the WT strain was predominant compared to the deleted strain Δ0160 at the end of the experiment. Then, in vivo experiments were performed using a GIT colonization mouse model. Several existing models of GIT colonization were compared while a novel one, combining ceftriaxone and amoxicillin, was developed. A GIT colonization was performed with each strain alone, and no significant difference was noticed. By contrast, significant results were obtained with co-colonization experiments. With WT + Δ0160 suspension, a significant advantage for the WT strain was observed from day 5 to the end of the protocol, suggesting the involvement of ern 0160 in GIT colonization. With Δ0160_0160 + Δ0160_pAT29 suspension, the strain with the empty vector took the advantage from day 3 to the end of the protocol, suggesting a deleterious effect of ern0160 overexpression. Altogether, these findings demonstrate the potential implication of Ern0160 in GIT colonization of E. faecium . Further investigations are needed for the identification of sRNA target(s) in order to decipher underlying molecular mechanisms., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Reissier, Le Neindre, Bordeau, Dejoies, Le Bot, Felden, Cattoir and Revest.)
- Published
- 2021
- Full Text
- View/download PDF
18. Streptogramins for the treatment of infections caused by Gram-positive pathogens.
- Author
-
Reissier S and Cattoir V
- Subjects
- Animals, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial, Gram-Positive Bacterial Infections microbiology, Humans, Pristinamycin administration & dosage, Pristinamycin pharmacology, Randomized Controlled Trials as Topic, Streptogramins pharmacology, Virginiamycin administration & dosage, Virginiamycin pharmacology, Gram-Positive Bacteria drug effects, Gram-Positive Bacterial Infections drug therapy, Streptogramins administration & dosage
- Abstract
Introduction: Streptogramins (pristinamycin and quinupristin-dalfopristin) can be interesting options for the treatment of infections due to Gram-positive cocci, especially multidrug-resistant isolates., Areas Covered: This review provides an updated overview of structural and activity characteristics, mechanisms of action and resistance, pharmacokinetic/pharmacodynamic, and clinical use of streptogramins., Expert Opinion: The streptogramin antibiotics act by inhibition of the bacterial protein synthesis. They are composed of two chemically distinct compounds, namely type A and type B streptogramins, which exert a rapid bactericidal activity against a wide range of Gram-positive bacteria (including methicillin-resistant staphylococci and vancomycin-resistant enterococci). Several mechanisms of resistance have been identified in staphylococci and enterococci but the prevalence of streptogramin resistance among clinical isolates remains very low. Even if only a few randomized clinical trials have been conducted, the efficacy of pristinamycin has been largely demonstrated with an extensive use for 50 years in France and some African countries. Despite its effectiveness in the treatment of severe Gram-positive bacterial infections demonstrated in several studies and the low rate of reported resistance, the clinical use of quinupristin-dalfopristin has remained limited, mainly due to its poor tolerance. Altogether, streptogramins (especially pristinamycin) can be considered as potential alternatives for the treatment of Gram-positive infections.
- Published
- 2021
- Full Text
- View/download PDF
19. Distinct expression profiles of regulatory RNAs in the response to biocides in Staphylococcus aureus and Enterococcus faecium.
- Author
-
Dejoies L, Le Neindre K, Reissier S, Felden B, and Cattoir V
- Subjects
- Enterococcus faecium drug effects, Genome, Bacterial, Gram-Positive Bacterial Infections drug therapy, Gram-Positive Bacterial Infections microbiology, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Staphylococcus aureus drug effects, Transcriptome, Disinfectants pharmacology, Enterococcus faecium genetics, Gene Expression Profiling, Gene Expression Regulation, Bacterial drug effects, RNA, Small Untranslated genetics, Staphylococcus aureus genetics
- Abstract
The aim of the study was to characterize the antimicrobial activity of clinically-relevant biocides (chlorhexidine digluconate, benzalkonium chloride, PVP-iodine and triclosan) and to determine the sRNA expression profiles under biocide exposure in two major bacterial opportunistic pathogens, Enterococcus faecium and Staphylococcus aureus. In vitro activities were evaluated against S. aureus HG003 and E. faecium Aus0004. We determined MIC, MBC, sub-inhibitory concentrations (SIC) and growth curves under SIC conditions. sRNA expression study under SIC exposure of biocides was performed by RT-qPCR on 3 sRNAs expressed in S. aureus (RNAIII, SprD and SprX) and the first 9 sRNAs identified as expressed in E. faecium. MICs were higher against E. faecium than for S. aureus. Growth curves under increasing biocide concentrations highlighted two types of bactericidal activity: "on/off" effect for chlorhexidine, benzalkonium chloride, PVP-iodine and a "concentration-dependent" activity for triclosan. Exposure to biocide SICs led to an alteration of several sRNA expression profiles, mostly repressed. The distinct biocide activity profiles must be evaluated with other compounds and bacterial species to enrich the prediction of resistance risks associated with biocide usage. Biocide exposure induces various sRNA-mediated responses in both S. aureus and E. faecium, and further investigations are needed to decipher sRNA-driven regulatory networks.
- Published
- 2021
- Full Text
- View/download PDF
20. Evaluation of the Unyvero i60 ITI® multiplex PCR for infected chronic leg ulcers diagnosis.
- Author
-
Reissier S, Lazareth I, Adjiman L, Couzigou C, Vidal B, Mizrahi A, Nguyen Van JC, Pilmis B, Le Monnier A, and Lourtet-Hascoët J
- Subjects
- Anaerobiosis, Bacteria classification, Bacteria pathogenicity, Drug Resistance, Multiple, Bacterial genetics, Female, Humans, Male, Multiplex Polymerase Chain Reaction instrumentation, Paris, Prospective Studies, Prosthesis-Related Infections diagnosis, Sensitivity and Specificity, Bacteria isolation & purification, Leg Ulcer diagnosis, Leg Ulcer microbiology, Multiplex Polymerase Chain Reaction methods
- Abstract
Objectives: Unyvero i60 ITI multiplex PCR (mPCR) may identify a large panel of bacteria and antibiotic resistance genes. In this study, we compared results obtained by mPCR to standard bacteriology in chronic leg ulcer (CLU) infections., Methods: A prospective study, part of the interventional-blinded randomized study "ulcerinfecte" (NCT02889926), was conducted at Saint Joseph Hospital in Paris. Fifty patients with a suspicion of infected CLU were included between February 2017 and September 2018. Conventional bacteriology and mPCR were performed simultaneously on deep skin biopsies., Results: Staphylococcus aureus and Pseudomonas aeruginosa were the most detected pathogens. Regarding the global sensitivity, mPCR is not overcome to the standard culture. Anaerobes and slow growing bacteria were detected with a higher sensitivity rate by mPCR than standard culture., Conclusion: Unyvero i60 ITI multiplex PCR detected rapidly pathogenic bacteria in infected CLU especially anaerobes and slow growing bacteria and was particularly effective for patients previously treated with antibiotics., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
21. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
- Author
-
Reissier S, Saleh-Mghir A, Guerin F, Massias L, Ghout I, Sinel C, Cattoir V, and Cremieux AC
- Subjects
- Animals, Bacterial Load, Disease Models, Animal, Endocarditis, Bacterial microbiology, Female, Gram-Positive Bacterial Infections microbiology, Rabbits, Treatment Outcome, Anti-Bacterial Agents administration & dosage, Daptomycin administration & dosage, Endocarditis, Bacterial drug therapy, Enterococcus faecium drug effects, Gram-Positive Bacterial Infections drug therapy, Vancomycin Resistance
- Abstract
Objectives: Daptomycin has become a first-line therapeutic option for vancomycin-resistant Enterococcus faecium infective endocarditis (IE). Although high doses (≥8 mg/kg) are often recommended, optimal doses, particularly for strains with MICs close to the susceptibility breakpoint (4 mg/L), are still debated., Methods: Daptomycin efficacy at doses equivalent to 8 mg/kg daptomycin (DAP8) and 12 mg/kg daptomycin (DAP12) in humans was evaluated in a rabbit model of aortic valve IE induced by 108 cfu of E. faecium reference strain Aus0004 (daptomycin MIC = 2 mg/L) or its in vitro mutant strain Mut4 (daptomycin MIC = 4 mg/L). Treatment began 48 h post-inoculation and lasted 5 days., Results: With Aus0004, the median log10 cfu/g of vegetations was significantly lower after DAP8 and DAP12 versus controls [6.05 (n = 12) and 2.15 (n = 10) versus 9.14 (n = 11), respectively; P < 0.001], with DAP12 being more effective than DAP8 concerning vegetation bacterial load (P < 0.001) and percentages of sterile vegetations (100% versus 0%, respectively; P < 0.001). Daptomycin-resistant Aus0004 mutants were detected in 8.3% of DAP8-treated vegetations. With Mut4, the median log10 cfu/g of vegetations was significantly lower after DAP8 and DAP12 versus controls [7.7 (n = 11) and 6.95 (n = 10) versus 9.59 (n = 11), respectively; P = 0.001 and P = 0.002], without any between-dose difference, but no vegetation was sterile. Moreover, 7 of 11 (63.6%) and 7 of 9 (77.8%) vegetations contained resistant mutants after DAP8 and DAP12, respectively., Conclusions: DAP12 was the most successful strategy against IE due to a WT E. faecium strain (daptomycin MIC = 2 mg/L). To treat IE strains with MIC = 4 mg/L, DAP8 or DAP12 monotherapy was poorly effective with the risk of resistant mutant emergence. Reassessment of the daptomycin susceptibility breakpoint for enterococci seems necessary.
- Published
- 2018
- Full Text
- View/download PDF
22. The natural statistics of blur.
- Author
-
Sprague WW, Cooper EA, Reissier S, Yellapragada B, and Banks MS
- Subjects
- Adult, Contrast Sensitivity physiology, Fixation, Ocular physiology, Fovea Centralis, Humans, Male, Visual Acuity physiology, Young Adult, Refractive Errors physiopathology, Visual Fields physiology, Visual Perception physiology
- Abstract
Blur from defocus can be both useful and detrimental for visual perception: It can be useful as a source of depth information and detrimental because it degrades image quality. We examined these aspects of blur by measuring the natural statistics of defocus blur across the visual field. Participants wore an eye-and-scene tracker that measured gaze direction, pupil diameter, and scene distances as they performed everyday tasks. We found that blur magnitude increases with increasing eccentricity. There is a vertical gradient in the distances that generate defocus blur: Blur below the fovea is generally due to scene points nearer than fixation; blur above the fovea is mostly due to points farther than fixation. There is no systematic horizontal gradient. Large blurs are generally caused by points farther rather than nearer than fixation. Consistent with the statistics, participants in a perceptual experiment perceived vertical blur gradients as slanted top-back whereas horizontal gradients were perceived equally as left-back and right-back. The tendency for people to see sharp as near and blurred as far is also consistent with the observed statistics. We calculated how many observations will be perceived as unsharp and found that perceptible blur is rare. Finally, we found that eye shape in ground-dwelling animals conforms to that required to put likely distances in best focus.
- Published
- 2016
- Full Text
- View/download PDF
23. Fatal nosocomial meningitis caused by Mycoplasma hominis in an adult patient: case report and review of the literature.
- Author
-
Reissier S, Masson R, Guérin F, Viquesnel G, Petitjean-Lecherbonnier J, Pereyre S, Cattoir V, and Isnard C
- Subjects
- Adult, Fatal Outcome, Humans, Male, Subarachnoid Hemorrhage surgery, Cross Infection mortality, Meningitis, Bacterial mortality, Mycoplasma Infections mortality, Mycoplasma hominis
- Abstract
Meningitis due to Mycoplasma hominis in adults is rarely described, with only three cases having been reported to date. A case of fatal meningitis in a 39-year-old patient after a neurosurgical procedure for a subarachnoid haemorrhage is reported herein. Identification and treatment were significantly delayed because of the rarity of the aetiology and difficulty identifying this organism with the routinely used conventional methods, such as Gram staining and agar growth on standard agar plates. Clinical procedures and the treatment of 'culture-negative' central nervous system infections is a real challenge for clinical microbiologists and clinicians, and M. hominis has to be considered as a potential, although very uncommon, pathogen., (Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
24. In vitro antimicrobial susceptibility of Alloscardovia omnicolens and molecular mechanisms of acquired resistance.
- Author
-
Isnard C, Lienhard R, Reissier S, Rodriguez S, Krähenbühl J, Liassine N, Guérin F, and Cattoir V
- Subjects
- Actinobacteria isolation & purification, Base Sequence, Gram-Positive Bacterial Infections diagnosis, Gram-Positive Bacterial Infections microbiology, Humans, Molecular Sequence Data, Mutation, RNA, Ribosomal, 23S chemistry, RNA, Ribosomal, 23S genetics, Sequence Alignment, Actinobacteria drug effects, Actinobacteria genetics, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial, Microbial Sensitivity Tests
- Abstract
All the 31 isolates of Alloscardovia omnicolens exhibited low MICs for β-lactams, glycopeptides, linezolid, tetracyclines, and cotrimoxazole. One strain showed MICs ≥256μg/mL for both erythromycin and clindamycin with a single point mutation in 23S rRNA. One strain likely had acquired fluoroquinolone resistance associated with a unique mutation in ParC., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.